Long-term cervical precancer outcomes after a negative DNA- or RNA-based human papillomavirus test result

Talia H R Strang,Anna Gottschlich,Darrel A Cook,Laurie W Smith,Lovedeep Gondara,Eduardo L Franco,Dirk J VAN Niekerk,Gina S Ogilvie,Mel Krajden

American Journal of Obstetrics and Gynecology（2021）

引用 8|浏览1

暂无评分

摘要

Among participants who were HPV negative at baseline, the long-term risk of CIN2+/CIN3+ did not significantly differ regardless of whether DNA- or RNA-based human papillomavirus testing assays were used. Screening program decision-makers can be confident that for women who test negative for HPV, DNA- and RNA-based assays have similar CIN2+ outcomes over many years.

查看译文

关键词

cervical cancer,cervical cancer screening tests,cervical intraepithelial neoplasia,human papillomavirus,human papillomavirus DNA tests,human papillomavirus RNA tests,human papillomavirus testing

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要